Key Takeaways
- • Balyasny Asset Management is launching Atlas Growth, its first dedicated venture capital fund, targeting $350 million in capital with a focus on growth-stage enterprise technology companies where mega-cap VC funds are not active.
- • The fund will operate through a new San Francisco-based affiliate, BAM Corner Point, and will be managed by Rashmi Gopinath (formerly general partner at B Capital) and Kristin Baker Spohn (formerly general partner at CRV), both with established track records in venture investing.
- • Balyasny is entering the venture market at a potential inflection point following a severe downturn: more than 1,200 venture-backed unicorns remain unexited since the 2022 technology market collapse, and "dried up liquidity" from hedge fund crossover capital has constrained late-stage and growth deals.
- • PitchBook's 2025 venture outlook anticipates market improvement despite ongoing headwinds, with 40 percent of U.S. venture-backed companies expected to face flat or down rounds, while additional companies may exit the funding cycle entirely.
- • Balyasny joins Tiger Global and Coatue Management in establishing standalone venture vehicles, signaling hedge fund appetite to capture opportunities in a capital-constrained venture ecosystem.
Summary
The fund is led by two experienced venture investors: Rashmi Gopinath, previously a general partner at B Capital, and Kristin Baker Spohn, formerly a general partner at CRV. According to sources familiar with the effort, the fund targets an underserved segment of the market where "big mega cap VC funds aren't playing and where potential portfolio companies are not being served." This positioning reflects a deliberate strategy to identify opportunities in gaps left by larger venture players during a prolonged market correction.
The venture sector has faced significant headwinds since the 2022 technology and growth stock market collapse. CB Insights data reveals that more than 1,200 venture-backed unicorns—companies valued above $1 billion—remain unexited through either public offerings or acquisitions. PitchBook identified a critical constraint in late-stage funding: the dearth of "crossover capital" from hedge funds running venture strategies has reduced availability of late-stage and venture growth financing. This liquidity shortage has been particularly acute in 2024 and early 2025.
However, market conditions may be stabilizing. PitchBook's 2025 venture outlook anticipates improvements, though it cautions that structural challenges persist. The firm projects that flat and down rounds will continue at elevated levels, and additional venture-backed companies may be forced to shut down or exit the funding cycle. Despite these headwinds, the improving backdrop and demonstrated appetite from established players like Balyasny suggest that selective venture investors with differentiated strategies may find compelling deployment opportunities in 2025.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.